Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Buys 29,112 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 29,112 shares of the firm’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was bought at an average cost of $0.78 per share, for a total transaction of $22,707.36. Following the completion of the transaction, the chief executive officer now directly owns 15,006,863 shares of the company’s stock, valued at approximately $11,705,353.14. The trade was a 0.19 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Retractable Technologies Price Performance

Retractable Technologies stock opened at $0.85 on Friday. The firm has a fifty day moving average of $0.68 and a 200-day moving average of $0.82. Retractable Technologies, Inc. has a 52-week low of $0.56 and a 52-week high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $25.40 million, a P/E ratio of -1.57 and a beta of 1.94.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Retractable Technologies in a report on Wednesday. They set a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.